With over 80 years of experience, Southern Research is a trusted partner in vaccine development, offering comprehensive preclinical services that accelerate the journey from discovery to clinical trials. Our expertise spans various vaccine modalities, including mRNA, viral vector, live-attenuated, inactivated, and recombinant protein-based vaccines.
Our state-of-the-art facilities, including BSL-2 and BSL-3 laboratories, enable us to conduct rigorous safety and efficacy assessments. We provide end-to-end support encompassing feasibility studies, immunogenicity testing, toxicology, and manufacturing process development. Our collaborative approach ensures that each project is tailored to meet specific goals and regulatory requirements.
At Southern Research, we are committed to advancing global health by delivering innovative solutions in vaccine development. We look forward to engaging with fellow experts at the World Vaccine Congress Europe 2025 to forge partnerships that drive the next generation of vaccines.